NDC 72205-238-64
nilotinib 150 mg/1
nilotinib · CAPSULE
Nilotinib is a kinase inhibitor capsule taken by mouth that is used to treat certain types of blood cancer, particularly chronic myeloid leukemia. It works by blocking specific proteins that help cancer cells grow and divide.
Key Facts
- Brand Name
- nilotinib
- Generic Name
- nilotinib
- NDC Code (Package)
72205-238-64- NDC Code (Product)
72205-238- Manufacturer
- Novadoz Pharmaceuticals LLC
- Strength
- 150 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA218544
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/19/2025
Recall History
No Recall HistoryView Full Drug Page
nilotinib — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.